These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12817158)

  • 1. Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription database.
    Hamann J; Ruppert A; Auby P; Pugner K; Kissling W
    Int Clin Psychopharmacol; 2003 Jul; 18(4):237-42. PubMed ID: 12817158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug prescription patterns in schizophrenia outpatients: analysis of data from a German health insurance fund.
    Weinbrenner S; Assion HJ; Stargardt T; Busse R; Juckel G; Gericke CA
    Pharmacopsychiatry; 2009 Mar; 42(2):66-71. PubMed ID: 19308881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
    Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
    Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An audit of outpatient antipsychotic usage in the three health sectors of Auckland, New Zealand.
    Humberstone V; Wheeler A; Lambert T
    Aust N Z J Psychiatry; 2004 Apr; 38(4):240-5. PubMed ID: 15038803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of antipsychotic prescription to patients with schizophrenia in Korea: results from the health insurance review & assessment service-national patient sample.
    Park SC; Lee MS; Kang SG; Lee SH
    J Korean Med Sci; 2014 May; 29(5):719-28. PubMed ID: 24851031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hidden magnitude of polypharmacy: using defined daily doses and maximum licensed daily doses to measure antipsychotic load.
    Nguyen ML; Sunderland B; Lim S; Hattingh L; Chalmers L
    Int J Clin Pharm; 2019 Dec; 41(6):1642-1651. PubMed ID: 31677120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
    Moisan J; Grégoire JP
    Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012.
    Bachmann CJ; Lempp T; Glaeske G; Hoffmann F
    Dtsch Arztebl Int; 2014 Jan; 111(3):25-34. PubMed ID: 24606780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient antipsychotic drug use in children and adolescents in Germany between 2004 and 2011.
    Schröder C; Dörks M; Kollhorst B; Blenk T; Dittmann RW; Garbe E; Riedel O
    Eur Child Adolesc Psychiatry; 2017 Apr; 26(4):413-420. PubMed ID: 27623818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with high-dose antipsychotic prescriptions in outpatients with schizophrenia: An analysis of claims data from a Japanese prefecture.
    Takahashi T; Otsubo T; Kunisawa S; Sasaki N; Imanaka Y
    Neuropsychopharmacol Rep; 2020 Sep; 40(3):224-231. PubMed ID: 32452649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National changes in oral antipsychotic treatment for people with schizophrenia in primary care between 1998 and 2007 in the United Kingdom.
    Prah P; Petersen I; Nazareth I; Walters K; Osborn D
    Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):161-9. PubMed ID: 21858898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of antipsychotic and anticholinergic prescribing for hospital inpatients.
    Paton C; Lelliott P; Harrington M; Okocha C; Sensky T; Duffett R
    J Psychopharmacol; 2003 Jun; 17(2):223-9. PubMed ID: 12870571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of patients' preexisting metabolic risk factors on the choice of antipsychotics by office-based physicians.
    Li C; Mittal D; Owen RR
    Psychiatr Serv; 2011 Dec; 62(12):1477-84. PubMed ID: 22193796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National prescribing patterns in the management of extrapyramidal symptoms among patients with schizophrenia.
    Luo RD; Belleti DA; Tran D; Arcona S; Salen PN
    Int J Psychiatry Med; 2002; 32(3):261-9. PubMed ID: 12489701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior antipsychotic prescribing in patients currently receiving clozapine: a case note review.
    Taylor DM; Young C; Paton C
    J Clin Psychiatry; 2003 Jan; 64(1):30-4. PubMed ID: 12590620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosage patterns of antipsychotic drugs for the treatment of schizophrenia in Swedish ambulatory clinical practice--a highly individualized therapy.
    Bingefors K; Isacson D; Lindström E
    Nord J Psychiatry; 2003; 57(4):263-9. PubMed ID: 12888400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona.
    Gaviria AM; Franco JG; Aguado V; Rico G; Labad J; de Pablo J; Vilella E
    PLoS One; 2015; 10(10):e0139403. PubMed ID: 26427051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription practices in the treatment of agitation in newly hospitalized Chinese schizophrenia patients: data from a non-interventional naturalistic study.
    Zhang SZ; Mu YG; Liu Q; Shi Y; Guo LH; Li LZ; Yang FD; Wang Y; Li T; Mei QY; He HB; Chen ZY; Su ZH; Liu TB; Xie SP; Tan QR; Zhang JB; Zhang CP; Sang H; Mi WF; Zhang HY
    BMC Psychiatry; 2019 Jul; 19(1):216. PubMed ID: 31291931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing of antipsychotic medication in a medicaid population: use of polytherapy and off-label dosages.
    Kogut SJ; Yam F; Dufresne R
    J Manag Care Pharm; 2005; 11(1):17-24. PubMed ID: 15667230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.